Imelda Bates

Imelda Bates

Auto-generated profile, based on publicly available information

Imelda Bates

Centre for Capacity Research, Liverpool School of Tropical Medicine, Liverpool, England

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in The Lancet
Verified
Journal Article
Closed access
MAMark Amexo
Mark Amexo
RTRachel Tolhurst
Rachel Tolhurst
GBGuy Barnish
Guy Barnish
IBImelda Bates
Imelda Bates

28 February 2008 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JCJob C.J. Calis
Job C.J. Calis
KPKamija S. Phiri
Kamija S. Phiri
EFE. Brian Faragher
E. Brian Faragher
BBBernard J. Brabin
Bernard J. Brabin
IBImelda Bates
Imelda Bates
MHMichaël Boele van Hensbroek
Michaël Boele van Hensbroek
Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied.

1 May 2004 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
IBImelda Bates
Imelda Bates
CFCaroline Fenton
Caroline Fenton
JGJanet Gruber
Janet Gruber
DLDavid Lalloo
David Lalloo
ALAntonieta Medina Lara
Antonieta Medina Lara
RTRachel Tolhurst
Rachel Tolhurst

15 September 2008 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
IBI Bates
I Bates
GCGk Chapotera
Gk Chapotera
SMS McKew
S McKew
NBN Van Den Broek
N Van Den Broek

1 April 2000 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
PNPaul Newton
Paul Newton
YSYupin Suputtamongkol
Yupin Suputtamongkol
PTPaktiya Teja-Isavadharm
Paktiya Teja-Isavadharm
SPSasithon Pukrittayakamee
Sasithon Pukrittayakamee
VNV Navaratnam
V Navaratnam
NWNicholas White
Nicholas White
The pharmacokinetic properties of oral and intravenous artesunate (2 mg/kg of body weight) were studied in 19 adult patients with acute uncomplicated Plasmodium falciparum malaria by using a randomized crossover design. A sensitive bioassay was used to measure the antimalarial activity in plasma which results from artesunate and its principal metabolite, dihydroartemisinin. The oral study was repeated with 15 patients during convalescence. The mean absolute oral bioavailability of the antimalarial agent in patients with acute malaria was 61% (95% confidence interval [CI], 52 to 70%). The absorption and elimination of oral artesunate were rapid, with a mean elimination half-life of antimalarial activity of 43 min (95% CI, 33 to 53 min). Following oral administration to patients with acute falciparum malaria, peak antimalarial activity in plasma and the area under the plasma concentration-time curve were approximately double those during convalescence and the apparent volume of distribution and clearance were approximately half those during convalescence ( P ≤ 0.005). Acute malaria is associated with a significant reduction in the clearance of artesunate-associated antimalarial activity.

18 February 2005 in Malaria Journal
Verified
Journal Article
Open access
PDF file
MDMartin J Donnelly
Martin J Donnelly
PMPJ McCall
PJ McCall
CLChristian Lengeler
Christian Lengeler
IBImelda Bates
Imelda Bates
UDUmberto D'ALessandro
Umberto D'ALessandro
CMClifford Mutero
Clifford Mutero
There are already 40 cities in Africa with over 1 million inhabitants and the United Nations Environmental Programme estimates that by 2025 over 800 million people will live in urban areas. Recognizing that malaria control can improve the health of the vulnerable and remove a major obstacle to their economic development, the Malaria Knowledge Programme of the Liverpool School of Tropical Medicine and the Systemwide Initiative on Malaria and Agriculture convened a multi-sectoral technical consultation on urban malaria in Pretoria, South Africa from 2nd to 4th December, 2004. The aim of the meeting was to identify strategies for the assessment and control of urban malaria. This commentary reflects the discussions held during the meeting and aims to inform researchers and policy makers of the potential for containing and reversing the emerging problem of urban malaria.